Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Suzhou, Jiangsu, China
Founded Date: 2011-01-01
Last Funding Date: 2021-02-11
Total Funding: 155000000.0
Estimated Revenue: $1M to $10M
Investors Number: 11.0
Industry: End-to-End Drug Development